Search results for "AEM"

showing 10 items of 1006 documents

Bone status in adolescents and young adults with type 1 diabetes: a 10-year longitudinal study

2020

Introduction: This study presents a 10-year longitudinal assessment of bone status in adolescents and young adults with type 1 diabetes (T1D). Material and methods: Thirty-two patients (12 female, aged 20.5 ± 3.93 years, T1D duration 13.9 ± 1.97 years) were studied using quantitative ultrasound (QUS) and dual-energy X-ray absorptiometry (DXA). Standard deviation scores (SDS) for these results were calculated. The following clinical parameters were analysed: sex, age, T1D duration, anthropometric parameters, daily insulin requirement (DIR), mean glycated haemoglobin (HbA1c) in the year preceding the examination, medication other than insulin, history of bone fractures, and comorbidities. Res…

MalePediatricsmedicine.medical_specialtyLongitudinal studyAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBone and BonesAnthropometric parametersYoung AdultEndocrinologyAbsorptiometry PhotonBone DensitymedicineHumansReference populationLongitudinal StudiesYoung adultGlycated haemoglobinType 1 diabetesbusiness.industryInsulinmedicine.diseasetype 1 diabetes; glycaemic control; bone status; quantitative ultrasound; dual X-ray absorptiometryQuantitative ultrasoundDiabetes Mellitus Type 1OsteoporosisFemalebusinessEndokrynologia Polska (Polish Journal of Endocrinology)
researchProduct

Stroke care organization overcomes the deleterious ‘weekend effect’ on 1-month stroke mortality: a population-based study

2013

Background and purpose Suffering a stroke during the weekend is associated with a poorer prognosis. The impact of implementing a dedicated stroke care network in Dijon, France, in 2003 on 30-day mortality in strokes/transient ischaemic attacks (TIA) occurring during weekends/bank holidays was evaluated. Methods All cases of stroke and TIA from 1985 to 2010 were identified from a population-based registry, using multiple overlapping sources of information. Demographics and clinical data were recorded. Cox regression models were used to evaluate associations between day of onset (weekdays versus weekends/bank holidays) and 30-day all-cause mortality. Data were stratified according to time per…

MalePediatricsmedicine.medical_specialtyWeekend effectPopulationPopulationTransient ischaemic attacksStroke careCommunity NetworksBrain Ischemiaparasitic diseasesHumansMedicinecardiovascular diseaseseducationStrokeAgedHolidaysAged 80 and overIntracerebral hemorrhageAnalysis of Varianceeducation.field_of_studybusiness.industryProportional hazards modelHazard ratioMiddle Agedmedicine.diseaseStrokeTreatment OutcomeNeurologyIschemic Attack TransientData Interpretation StatisticalEmergency medicineRegression AnalysisFemaleFranceNeurology (clinical)businessIntracranial Hemorrhageshuman activitiesEuropean Journal of Neurology
researchProduct

Activated prothrombin complex concentrate (FEIBA® ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry

2019

MalePediatricsmedicine.medical_specialtyhaemophiliacoagulation factors030204 cardiovascular system & hematologyHemophilia AHaemophilia03 medical and health sciences0302 clinical medicineAcquired haemophiliaHumansMedicinecoagulation factorProspective StudiesRegistriesProspective cohort studyActivated prothrombin complex concentrateRetrospective Studiesbleeding disorders; coagulation factors; factor VIII; haemophilia; Blood Coagulation Factors; Female; Hemophilia A; Humans; Italy; Male; Prospective Studies; Retrospective Studies; Registriesbleeding disordersbleeding disorderbusiness.industryRetrospective cohort studyHematologymedicine.diseaseBlood Coagulation FactorsItalyfactor VIIIFemalebusiness030215 immunologyBritish Journal of Haematology
researchProduct

Morphological and genomic characterisation of the Schistosoma hybrid infecting humans in Europe reveals admixture between Schistosoma haematobium and…

2021

Schistosomes cause schistosomiasis, the world’s second most important parasitic disease after malaria in terms of public health and social-economic impacts. A peculiar feature of these dioecious parasites is their ability to produce viable and fertile hybrid offspring. Originally only present in the tropics, schistosomiasis is now also endemic in southern Europe. Based on the analysis of two genetic markers the European schistosomes had previously been identified as hybrids between the livestock- and the human-infective species Schistosoma bovis and Schistosoma haematobium, respectively. Here, using PacBio long-read sequencing technology we performed genome assembly improvement and annotati…

MalePhysiologyIntrogressionEggsRC955-962SnailsDisease Vectors0302 clinical medicineMedical ConditionsReproductive PhysiologyArctic medicine. Tropical medicineInvertebrate GenomicsMedicine and Health SciencesBody SizeSchistosomiasis0303 health sciences[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]EukaryotaGenomics3. Good healthEuropeInfectious DiseasesSchistosoma bovisSchistosoma haematobiumSchistosomaFemalePublic aspects of medicineRA1-1270SchistosomesResearch ArticleEvolutionary ProcessesBulinus030231 tropical medicine03 medical and health sciencesHelminthsParasitic diseaseparasitic diseasesGeneticsParasitic DiseasesAnimalsHumans[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology030304 developmental biologyEvolutionary BiologyGenome Helminth[SDV.GEN]Life Sciences [q-bio]/GeneticsChimeraPublic Health Environmental and Occupational HealthOrganismsBiology and Life SciencesPaleontologyInvertebratesAnimal GenomicsEarth SciencesHybridization GeneticPaleogeneticsZoology
researchProduct

Immunohistochemical evaluation of bone marrow lymphoid nodules in chronic myeloproliferative disorders

1991

One hundred and seventy bone marrow biopsies from patients with chronic myeloproliferative disorders (CMPDs) were evaluated for the presence of lymphoid nodules (LNs) and were immunostained using a panel of monoclonal antibodies (UCHL1, 4KB5 and L26) recognizing different lymphocyte antigens. LNs were found in 35% of cases of idiopathic thrombocythaemia, 24.6% of myelofibrosis/osteomyelosclerosis, 18.2% of polycythaemia vera 12.1% of chronic myeloid leukaemia and 19.2% of borderline cases. Varying degrees of immunohistochemical positivity for the three antibodies tested were found. LNs were always made up of variable proportions of both T- and B-lymphocytes with a prevalence of T-cells. Thi…

MalePolycythaemiaPathologymedicine.medical_specialtymedicine.drug_classMonoclonal antibodyPathology and Forensic MedicineBone Marrowhemic and lymphatic diseasesmedicineHumansLymphocytesMyelofibrosisMolecular BiologyAgedMyeloproliferative Disordersintegumentary systembiologybusiness.industryAntibodies MonoclonalCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryChronic myeloproliferative disordersmedicine.anatomical_structureChronic DiseaseMonoclonalbiology.proteinImmunohistochemistryFemaleBone marrowAntibodybusinessVirchows Archiv A Pathological Anatomy and Histopathology
researchProduct

Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echin…

2011

SUMMARYWith the current paucity of vaccine targets for parasitic diseases, particularly those in childhood, the aim of this study was to compare protein expression and immune cross-reactivity between the trematodes Schistosoma haematobium, S. bovis and Echinostoma caproni in the hope of identifying novel intervention targets. Native adult parasite proteins were separated by 2-dimensional gel electrophoresis and identified through electrospray ionisation tandem mass spectrometry to produce a reference gel. Proteins from differential gel electrophoresis analyses of the three parasite proteomes were compared and screened against sera from hamsters infected with S. haematobium and E. caproni fo…

MaleProteomicsProteome/dk/atira/pure/subjectarea/asjc/2400/2405ProteomicstrematodeimmunologyEXPERIMENTAL-INFECTIONS. bovis0302 clinical medicineCricetinaeEchinostoma/dk/atira/pure/subjectarea/asjc/2700/2725SchistosomiasisParasite hostingElectrophoresis Gel Two-DimensionalChildDIGEGENE-EXPRESSIONGel electrophoresisSchistosoma haematobiumEchinostomiasis0303 health sciencesBiomphalaria/dk/atira/pure/subjectarea/asjc/1100/1103IMMUNE-RESPONSESEchinostosma caproniHelminth ProteinsUp-RegulationPROTEIN DISULFIDE-ISOMERASE3. Good healthPhenotypeInfectious DiseasesProteomeSchistosoma haematobiumSchistosomaEchinostomaResearch ArticleFRIEDI TREMATODABulinus030231 tropical medicineMANSONICross ReactionsBiologyHost-Parasite InteractionsMicrobiologyS. haematobium03 medical and health sciencesproteomicsSpecies SpecificityDIAAnimalsHumansFasciola hepaticaPARASITE030304 developmental biologySchistosomaFASCIOLA-HEPATICAMOLECULAR-CLONINGMesocricetusANCYLOSTOMA-CANINUMbiology.organism_classificationvaccine developmentAntigens HelminthImmunologyAnimal Science and ZoologyParasitologyParasitology
researchProduct

Health-related quality of life and psychological well-being in elderly patients with haemophilia

2011

Many persons with severe haemophilia reach seniority thanks to effective treatment. There is no information on health-related quality of life (HRQoL) of these patients, who had lived for many years when regular replacement therapy was unavailable. Italian patients with severe haemophilia aged ≥65 years born in the 1940s or earlier were compared with men without bleeding disorders matched for age and geography. HRQoL was assessed via generic and disease-specific questionnaires. Potential associations with concomitant illnesses, orthopaedic status, physical functioning, cognitive status and depression were evaluated. In addition, the newly adapted HRQoL questionnaire specific for elderly pers…

MalePsychometricsHealth StatushaemophiliaComorbidityHemophilia AHemophilia BSettore MED/15 - Malattie Del SangueCross-Sectional StudiesItalyCase-Control StudiesSurveys and QuestionnairesActivities of Daily LivingQuality of LifeHumansFemaleAgedRetrospective Studies
researchProduct

Adipose tissue in obesity and obstructive sleep apnoea

2011

A European Respiratory Society research seminar on ‘‘Metabolic alterations in obstructive sleep apnoea (OSA)’’ was jointly organised in October 2009 together with two EU COST actions (Cardiovascular risk in the obstructive sleep apnoea syndrome, action B26, and Adipose tissue and the metabolic syndrome, action BM0602) in order to discuss the interactions between obesity and OSA. Such interactions can be particularly significant in the pathogenesis of metabolic abnormalities and in increased cardiovascular risk in OSA patients. However, studying the respective role of OSA and obesity is difficult in patients, making it necessary to refer to animal models or in vitro systems. Since most OSA p…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyLipoxygenaseAdipose tissueMiceInsulin resistancestomatognathic systemAnimalsHumansMedicineObesityHypoxiaIntensive care medicineDyslipidemiasInflammationSleep Apnea Obstructivebusiness.industryAdipocyte dyslipidaemia hypoxia liver dysfunction obesitySleep apneaHypoxia (medical)medicine.diseaseObesitySleep in non-human animalsRatsnervous system diseasesrespiratory tract diseasesOxidative StressAdipose TissuePhysical therapyFemaleInsulin ResistanceLiver dysfunctionMetabolic syndromemedicine.symptombusinessEuropean Respiratory Journal
researchProduct

Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.

2015

Summary The aim of this study was to elucidate more clearly the role of interleukin (IL)-18 in modulating the IL-22 pathway in primary Sjögren's syndrome (pSS) patients and in pSS-associated lymphomas. Minor salivary glands (MSGs) from patients with pSS and non-specific chronic sialoadenitis (nSCS), parotid glands biopsies from non-Hodgkin lymphomas (NHL) developed in pSS patients, were evaluated for IL-18, IL-22, IL-22 receptor 1 (IL-22R1), IL-22 binding protein (IL-22BP) and signal transducer and activator of transcription-3 (STAT-3) expression. MSGs IL-22R1-expressing cells were characterized by confocal microscopy and flow cytometry in pSS, nSCS and healthy controls. The effect of recom…

MaleSalivary Glandslaw.inventionInterleukin 22lawIL-22Immunology and AllergyMyeloid CellsIL-22R1Receptormedicine.diagnostic_testnon-Hodgkin lymphomaLymphoma Non-HodgkinInterleukin-17TranslationalInterleukin-18Lacrimal ApparatusInterleukinMiddle AgedHaematopoiesisSjogren's SyndromeIL-22BPRecombinant DNASjögren's syndromeInterleukin 18FemaleIL-18Signal TransductionAdultSTAT3 Transcription FactorImmunologyPrimary Cell CultureBiologyPeripheral blood mononuclear cellIL-18; IL-22; IL-22BP; IL-22R1; Sjögren's syndrome; non-Hodgkin lymphomaSialadenitisFlow cytometrystomatognathic systemmedicineHumansAgedInterleukinsMacrophagesReceptors InterleukinSettore MED/16 - Reumatologiastomatognathic diseasesGene Expression RegulationImmunologyLeukocytes MononuclearClinical and experimental immunology
researchProduct

Hepatitis B virus reactivation and alemtuzumab therapy

2005

Reactivation of hepatitis B virus infection in subjects receiving cytotoxic treatment for heamatological malignancies occurs in 21–53% of chronic HBsAg carriers and in an unknown number of HBsAg negative subjects harbouring occult HBV infection. Immmunotherapy with alemtuzumab, a humanized monoclonal antibody against CD52 epitopes on lymphocytes cells produces deep immunosuppression. We describe two subjects with chronic lymphocytic leukaemia and occult HBV infection who developed a virological and biochemical flare of hepatitis B following immunotherapy with alemtuzumab. One of them developed full blown hepatitis with seroreversion from anti-HBs to HBsAg after four weeks of alemtuzumab the…

MaleSettore MED/07 - Microbiologia E Microbiologia ClinicaHepatitis B virusHBsAgCD52Antibodies Neoplasmmedicine.medical_treatmenthepatitis B viruAntibodies Monoclonal Humanizedmedicine.disease_causeCampath-1HSettore MED/15 - Malattie Del SanguemedicineHumansAlemtuzumabImmunosuppression TherapyHepatitisHepatitis B virusSettore MED/12 - GastroenterologiaHepatitis B Surface Antigensbusiness.industryacute hepatitiAntibodies Monoclonalvirus diseasesLamivudineImmunosuppressionHematologyGeneral MedicineMiddle AgedHepatitis BHepatitis Bmedicine.diseaseLeukemia Lymphocytic Chronic B-Celldigestive system diseasesLamivudineDNA ViralImmunologyReverse Transcriptase InhibitorsAlemtuzumabFemaleVirus Activationbusinesschronic lymphocytic leukaemiamedicine.drugEuropean Journal of Haematology
researchProduct